Radiology
-
Randomized Controlled Trial
Triple-negative breast cancer: correlation between MR imaging and pathologic findings.
To retrospectively evaluate the magnetic resonance (MR) imaging findings of "triple-negative" breast cancer (ie, cancer that is estrogen receptor [ER] negative, progesterone receptor [PR] negative, and human epidermal growth factor receptor 2 [HER2] negative) and to compare them with those of breast cancers that are ER positive, PR positive, and HER2 negative. ⋯ Several MR imaging features might be used for detecting triple-negative breast cancer.